公司資料
Enveric Biosciences 股價、新聞與催化劑
- 股票代碼:
- ENVB
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.41 USD (-1.40%)
收盤價
最後更新: 2026年8月24日
8.17M USD
市值
股價為何變動
As of Aug 24, 2026, ENVB closed down 1.40% at $1.41. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Enveric Biosciences is a neuroscience company focused on next-generation psychedelic-inspired and other CNS therapies. Its story centers on mental-health biology and the search for differentiated neuropsychiatric treatments.
所在地與產業分類
Enveric is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.
商業模式特徵
The company depends on preclinical and early clinical work, translational validation, and capital support. Investors usually watch platform updates, strategic focus, and the ability to maintain a coherent CNS thesis.
生技產業定位
Enveric occupies a speculative neuroscience niche within biotech. It is a high-risk story where early platform proof matters a great deal.
未來催化劑
- Enveric’s catalysts are psycho-oncology and CNS-related programs, plus any update that shows the platform can still generate value. The market remains early-stage and data-sensitive.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。